Chemoinformaics analysis of Spirovetiva-1(10),7(11)-diene
| Molecular Weight | 206.373 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 11 |
| Exact Molecular Weight | 206.203 | nRing | 2 |
| Solubility: LogS | -5.695 | nHRing | 0 |
| Solubility: LogP | 5.494 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 42.3866 |
| nHD | 0 | BPOL | 26.0834 |
| QED | 0.54 |
| Synth | 4.429 |
| Natural Product Likeliness | 3.131 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.354 |
| MDCK | 0.0000141 |
| BBB | 0.492 |
| PPB | 0.981654 |
| VDSS | 3.622 |
| FU | 0.0241781 |
| CYP1A2-inh | 0.413 |
| CYP1A2-sub | 0.409 |
| CYP2c19-inh | 0.37 |
| CYP2c19-sub | 0.931 |
| CYP2c9-inh | 0.473 |
| CYP2c9-sub | 0.526 |
| CYP2d6-inh | 0.048 |
| CYP2d6-sub | 0.312 |
| CYP3a4-inh | 0.397 |
| CYP3a4-sub | 0.335 |
| CL | 16.467 |
| T12 | 0.09 |
| hERG | 0.028 |
| Ames | 0.01 |
| ROA | 0.036 |
| SkinSen | 0.247 |
| Carcinogencity | 0.149 |
| EI | 0.908 |
| Respiratory | 0.061 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.886998 |